Brief: Silexion Therapeutics Posts New Preclinical Data Showing Up To 97% Inhibition Of Cancer Cell Growth
31/07/2025 16:18
July 31 (Reuters) - Silexion Therapeutics Corp SLXN.O: SILEXION THERAPEUTICS ANNOUNCES NEW PRECLINICAL DATA SHOWING UP TO 97% INHIBITION OF CANCER CELL GROWTH, INCLUDING NEW EVIDENCE AGAINST NEW PREVIOUSLY UNTESTED KRAS MUTATION Source text: ID:nGNXXmvMq Further company coverage: SLXN.O ((Reuters.Briefs@thomsonreuters.com;))